CKD Bio Corp.
CKD Bio Corp. (KRX: 063160) is trading at ₩14,010.00, about ₹1,011 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 7.03% today. CKD Bio is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩13,750.00
Today's high
₩14,720.00
52 week low
₩11,770.00
52 week high
₩24,900.00
063160 opened at ₩14,560.00, closed previously at ₩15,070.00, and has traded between ₩11,770.00 and ₩24,900.00 over the past 52 weeks.
About
CKD Bio Corp., a South Korean company founded in 1941 and headquartered in Seoul, specializes in the production and distribution of pharmaceutical active ingredients (APIs). Their manufacturing processes leverage diverse technologies, including fermentation, chemical synthesis, and biotechnology. The company's extensive portfolio of APIs targets a broad spectrum of therapeutic applications, encompassing antibiotics, beta-lactamase inhibitors, immunosuppressants, oncology treatments, anti-obesity medications, dry eye remedies, antiviral and antituberculosis agents, antihyperlipidemics, and probiotics. Beyond its core manufacturing, CKD Bio Corp. also provides contract research, development, and manufacturing (CRDMO) services for APIs, pharmaceutical intermediates, and probiotic formulations. The company actively exports its products, establishing a global reach.
Key statistics
Avg. volume
36.98K
Market cap
₩76.86B
P/E Ratio
-7.16
Price-to-sales ratio
0.49
Enterprise value
₩255.23B
Free cash flow yield
-9.80%
Debt-to-equity ratio
1.24
Return on equity
-2.27%
ROIC
1.28%
Beta
0.33
Dividend yield
0.00%
Last dividend
₩0.00
Financial overview
Revenue
₩160.07B
Earnings per share
-₩526.16
Free cash flow
-₩10.95B
Net profit margin
-6.79%
Gross margin
8.61%
EBITDA
₩19.26B
Revenue growth
-6.80%
Similar securities
This is not an investment recommendation
CKD Bio for Indian investors
CKD Bio is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on CKD Bio for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneCKD Bio does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can I buy CKD Bio on Paasa?
CKD Bio (063160) has been listed on the Korea Exchange since 2000, in the Drug Manufacturers - Specialty & Generic industry. CKD Bio is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one CKD Bio share cost in rupees?
One CKD Bio share is ₩14,010.00 — about ₹1,011 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the CKD Bio price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on CKD Bio shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the CKD Bio price.
Does CKD Bio pay a dividend?
No. CKD Bio does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare CKD Bio shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on CKD Bio?
Yes. CKD Bio is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.